STOCK TITAN

Quest Diagnostics Launches Mobile Phlebotomy Service, Enabling Convenient At-Home Specimen Collection in the United States

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
DGX: Quest Diagnostics Launches Quest Mobile™, Expanding At-Home Specimen Collection Nationwide with 5,000 Trained Mobile Phlebotomists in 44 States by 2023
Positive
  • Quest Diagnostics is addressing the growing demand for at-home healthcare services with the launch of Quest Mobile™, offering convenience and choice to patients for specimen collection and lab testing. The company's innovative approach is based on expertise and scale, reflecting a broader trend towards at-home care. With 5,000 trained mobile phlebotomists, Quest Mobile will be available in 44 states by the end of 2023, providing access to over 800 tests for mobile collection with a physician's order. The company's commitment to broadening access to laboratory testing is evident through its history of championing innovations, such as online appointment scheduling and direct patient access to lab information.
Negative
  • None.

Quest Mobile™ has 5,000 trained mobile phlebotomists whose reach will extend to 44 states by the end of 2023

SECAUCUS, N.J., Nov. 9, 2023 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today announced the launch of Quest Mobile™, which makes it easier and more convenient for patients to have a specimen collected for lab testing nationwide. Patients can request an appointment for at-home specimen collection with a trained Quest Mobile phlebotomist for a broad range of laboratory tests in the comfort of their home.

"People increasingly value choice and convenience in healthcare, including lab testing. Quest Mobile provides an outstanding option for individuals to access critical testing services on their own terms, from a provider they trust for quality and service," said Patrick Plewman, Senior Vice President, Diagnostic Services, Quest Diagnostics. "Quest Mobile also reflects Quest's strategy to develop innovative solutions, based on our expertise and scale, to serve the evolving needs of customers, including greater interest in at-home care."

Based on the most accessible mobile collection healthcare network in the United States, the Quest Mobile service will be available in 44 states. Patients whose physicians or health providers order laboratory testing from Quest, including consumers requesting consumer-initiated testing services from questhealth.com, can now schedule a mobile phlebotomy appointment for a fee at Appointment.QuestDiagnostics.com.

Quest Mobile does not bill to a patient's health insurance, and patients will pay a $55 mobile collection fee at time of scheduling. The company is currently working with healthcare providers, health systems, and health plans to arrange commercial pricing to eliminate an out-of-pocket cost for patients.

Once scheduled, a trained Quest Mobile specialist will complete the patient's blood draw or other specimen collection at the individual's location and bring their specimen to a Quest Diagnostics patient service center – with no handoffs in specimen transport or processing to a third-party provider. Over 800 Quest tests are available for mobile collection with a physician's order, from routine cholesterol and diabetes screenings to prenatal carrier screenings and evaluations for Lyme disease, including other commonly ordered tests.

Quest's network of 5,000 trained mobile phlebotomists is believed to be the largest in the industry. The new service complements the company's current service options, which include online appointment scheduling and walk-in visits at one of Quest's 2,100 patient service centers as well as in-office phlebotomy at some health provider sites. Test ordering and reporting remains unchanged.

"Issues like access and convenience shouldn't prevent patients from receiving needed lab services," said Subu Ramachandran, Vice President and General Manager of Quest Diagnostics' ExamOne unit, which initially built the mobile phlebotomy network to support in-home health examinations for life insurance applicants. "Quest Mobile provides patients and physicians a seamless connection to Quest Diagnostic's laboratory testing, allowing us to work together for a healthier world – one life at a time."

Quest has a long history of championing innovations in service to broaden access to laboratory testing. The company was the first national provider of online appointment scheduling, in 2007, and is believed to be the first national commercial laboratory to facilitate direct patient access to lab information through a range of free channels in 2014.

For more information, visit www.QuestDiagnostics.com/Patients/Get-Tested/Quest-Mobile.

About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our nearly 50,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-launches-mobile-phlebotomy-service-enabling-convenient-at-home-specimen-collection-in-the-united-states-301983447.html

SOURCE Quest Diagnostics

FAQ

What is the name of the company launching Quest Mobile™?

Quest Diagnostics (NYSE: DGX) is the company launching Quest Mobile™.

How many trained mobile phlebotomists will Quest Mobile™ have by the end of 2023?

Quest Mobile™ will have 5,000 trained mobile phlebotomists reaching 44 states by the end of 2023.

What is the fee for a mobile phlebotomy appointment with Quest Mobile™?

Patients will pay a $55 mobile collection fee at the time of scheduling.

How many tests are available for mobile collection with a physician's order through Quest Mobile™?

Over 800 tests are available for mobile collection with a physician's order through Quest Mobile™.

Quest Diagnostics Inc.

NYSE:DGX

DGX Rankings

DGX Latest News

DGX Stock Data

15.26B
109.71M
0.43%
91.73%
2.29%
Medical Laboratories
Health Care and Social Assistance
Link
United States of America
SECAUCUS

About DGX

quest diagnostics (nyse: dgx) empowers people to take action to improve health outcomes. derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. quest annually serves one in three adult americans and half the physicians and hospitals in the united states, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. the company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (ap) services, & interpretive consultation through its medical & scientific staff of about 900 m.d.s & ph.d.s. the company reported 2014 revenues of $7.4 billion. quest diagnostics offers the most extensive clinical testing network in the u.s., with laborator